Status:
COMPLETED
Urine Metabolomics and Colorectal Cancer Screening
Lead Sponsor:
University of Alberta
Conditions:
Colorectal Cancer
Colorectal Polyps
Eligibility:
All Genders
18-90 years
Brief Summary
This is a prospective, multi-centered study to assess whether urine metabolomics can play a role in the screening of colorectal cancer (CRC). Urine samples will be collected from 1000 patients going t...
Eligibility Criteria
Inclusion
- For Screening group (normal colonoscopy \& colonic polyps):
- asymptomatic, 50-75 year old, without personal or family history of CRC/polyps
- asymptomatic, 40-75 year old, known personal or first-degree family history of either CRC or polyps
- For Cancer group:
- any patient with diagnosis of colorectal cancer
- any patient with diagnosis of prostate cancer
- any patient with diagnosis of breast cancer
Exclusion
- For screening group:
- hematochezia
- inflammatory bowel disease
- on anticoagulation for reasons other than atrial fibrillation
- significant co-morbidities
- For Cancer group:
- already had neoadjuvant treatment at time of urine collection
- no invasive cancer at time of urine collection
Key Trial Info
Start Date :
September 15 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2017
Estimated Enrollment :
2175 Patients enrolled
Trial Details
Trial ID
NCT01486745
Start Date
September 15 2008
End Date
July 31 2017
Last Update
April 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada